Senate Democrats introduced a bill to cap out-of-pocket costs at $5000 for traditional Medicare beneficiaries and expand low-income assistance. Traditional Medicare does not currently have a limit on ...
COA’s AI Playbook provides a structured, practice-oriented framework to prioritize AI use cases, align stakeholders, and ...
Learn how aggressive neuroendocrine carcinoma disrupts daily life—and why rapid treatment, strong caregiver support, and navigation resources matter. In this episode, ‘Current Treatments and Biomarker ...
AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...
CDC ended the federal response June 24, 2026, after risk diminished, releasing >100 deployed staff from the peak incident ...
Recent data from the National Cancer Institute (NCI) suggest that the number of people in the US diagnosed with diffuse large ...
From overtreating good-risk patients to searching for a cure, Adam Kittai, MD, Perlmutter Cancer Center, outlines where CLL ...
How longer-lasting therapies cut injection burden, boost adherence, and protect vision in AMD, DME, and RVO with ...
As discussed at a recent IVBM event, Robert Kratzke, MD, outlines essential biomarkers, NGS panel selection, and next steps ...
National health spending is forecast to approach $9 trillion by 2034, increasing faster than GDP and consuming 20.6% of the ...
Retrospective single-center review of 80 HFrEF patients added SGLT2 inhibitors on stable guideline-directed therapy, with ...
On National HIV Testing Day, getting tested remains a gateway to prevention and treatment, but improving access alone is not enough. Expanding access to PrEP, PEP, pharmacists, long-acting therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results